Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Montfermeil, France Clinical Trials

A listing of Montfermeil, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (14) clinical trials

A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab

NUMBER OF PATIENTS : 238 patients in 20 sites in France RECRUITMENT PERIOD : The trial duration for each patient will be 144 weeks MAIN ENDPOINT : At week 48 success defined by: Endoscopic remission defined by an endoscopic Mayo score 0 SECONDARY ENDPOINTS: At W48 Clinical remission (Clinical remission ...

Phase

0.31 miles

Learn More »

Impact of a Front-of-pack Nutrition Labelling on Food Purchases in Contract Catering

The introduction of front-of-pack nutrition labelling is thought to help consumers making healthier food choices at the point-of-purchase. In 2017, the French government has selected the Nutri-Score as single front-of-pack nutrition label to be applied on food products sold in French supermarkets, on a voluntary basis. Some studies have found ...

Phase N/A

5.97 miles

Learn More »

Tracheobronchial Bioengineering Using Aortic Matrices for Airway Reconstruction

In the context of end-stage tracheobronchial disease (in particular tracheal or carinal indication) this technic propose a therapeutic alternative, in the context of bronchial replacement it allows to avoid pneumonectomy. The advantages are to reduce mortality at 90 days, functional consequences and long-term complications. In this observationnel study, data were ...

Phase N/A

6.77 miles

Learn More »

Evaluation of Predictive Factors for Ruptures of Meije Duo Size 1 and 2 Femoral Stems in Hip Replacement Surgery

First, patients with Meije Duo sizes 1 or 2, who had surgery from 2007 to 2014, will be preselected on medical records. The information notice will be sent to them by post. A period of reflection will be respected before contacting the patient to answer their questions concerning the research ...

Phase N/A

8.0 miles

Learn More »

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)

The main objective of this study is to evaluate the efficacy of venetoclax in combination with azacitidine to improve Relapse Free Survival (RFS) in AML patients compared to Best Supportive Care (BSC) when given as maintenance therapy following allogeneic stem cell transplantation (SCT). This study will have 2 parts: Part ...

Phase

8.26 miles

Learn More »

Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of Gadolinium

Meningioma, an extra-axial brain tumor developed at the expense of meninges, accounts for 35% of central nervous system tumors, and its incidence is estimated at 3% in large autopsy series. The current gold standard for screening and monitoring cerebral meningiomas is MRI with injection of gadoline-contrast product. However, the use ...

Phase N/A

8.4 miles

Learn More »

CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl)

The main objective of this study is to analyze a new noninvasive imaging examination, OCT angiography, in the evaluation of neovascular remodeling and early signs of recurrence of wet AMD undergoing treatment on OCTA and to correlate OCTA findings with SD-OCT findings.

Phase N/A

9.4 miles

Learn More »

Ilomedin in Septic Shock With Persistent Microperfusion Defects (I-MICRO)

In the 23 participating centers: patients with septic shock and persistent peripheral hypoperfusion despite hemodynamic optimization (skin mottling and/or finger skin recoloration time > 3sec, and/or knee skin recoloration time > 4sec), after 6 to 24 hours of norepinephrine onset will be eligible for randomization. Patients fulfilling the eligibility criteria ...

Phase

9.7 miles

Learn More »

Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation

850 million individuals suffer from chronic kidney disease (CKD), while diabetes, cancer, and HIV/AIDS affect 422, 42, and 37 million individuals, respectively. End stage renal disease (ESRD) hence places a heavy burden on health systems worldwide. Linked to that, the kidney-disease-associated mortality rate worldwide has risen over the past decade, ...

Phase N/A

9.7 miles

Learn More »

Personalized Medicine for Membranous Nephropathy

Randomized, open label, multicentre (20 sites), prospective trial comparing the efficacy of two therapeutic strategies to obtain clinical remission 1 year after diagnosis of Idiopathic Membranous Nephropathy with nephrotic syndrome and anti-PLA2R1 (phospholipase A2 receptor 1) antibodies GEMRITUX protocol: 6 months of symptomatic antihypertensive and antiproteinuric therapy, and if the ...

Phase

9.72 miles

Learn More »